(Q84596445)

English

Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases

scientific article published on 26 July 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

F Zohren

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

T Schroeder

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A Czibere

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

R Fenk

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

I Bruns

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

M Kondakci

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

C Saure

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

R Haas

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

G Kobbe

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

26 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

46

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

747-755

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661230%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

https://scigraph.springernature.com/pub.10.1038/bmt.2010.167

0 references

Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84596445&oldid=1754696351"